Andrey V. Marchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrey V. Marchenko has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Pavel A. Myalyuk
Federal Center for Cardiovascular Surgery named after S.G. Sukhanov, Ministry of Health of the Russian Federation, Perm
12 shared publications - Alexey S. Vronskiy
Clinical Cardiology Dispensary
8 shared publications - Yuriy S. Sinelnikov
S.G. Sukhanov Federal Center for Cardiovascular Surgery
8 shared publications - Vyacheslav A. Belov
Межрегиональная общественная организация детских кардиохирургов «Общество специалистов по врожденным порокам сердца», Санкт-Петербург, Российская Федерация; Федеральное государственное бюджетное учреждение «Федеральный центр сердечно-сосудистой хирургии им. С.Г. Суханова» Министерства здравоохранения Российской Федерации, Пермь, Российская Федерация
6 shared publications - A. A. Petrishchev
Federal Center for Cardiovascular Surgery named after S.G. Sukhanov
5 shared publications - Bakytbek K. Kadyraliev
FCCS named after S.G. Sukhanov
5 shared publications
Latest Publications
- 1 January 2026
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 32 (1)
Carotid-axillary prosthetics as a surgical treatment option for subclavian artery aneurysm (clinical case)
- 1 January 2026
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 32 (1)
Carotid-axillary prosthetics as a surgical treatment option for subclavian artery aneurysm (clinical case)
- Open Access
- 13 July 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (2) , 159-167
Aortic root surgery in the beating heart: a case series
Aim: To describe the technique of surgical intervention on the aorta and aortic valve under working heart conditions with constant antegrade coronary myocardial perfusion and / or in combination with cardioplegic cardiac arrest; and also to assess the effectiveness of this method of myocardial protection and the possibility of its further use in aortic surgery.Materials and methods: From March to November 2024, 12 patients underwent planned surgery at the S.G. Sukhanov Federal Center for Cardiovascular Surgery of the Ministry of Health of Russia (Perm). The average age was 57.75±9.8 years – 10 men (83.7%), 2 women (16.3%). All of them underwent off-pump aortic replacement: supracoronary aortic replacement (1 patient); supracoronary aortic replacement and aortic valve replacement (1 patient); supracoronary aortic replacement and coronary artery bypass grafting (CABG) using radiofrequency ablation (RFA) (1 patient); Bentall-De Bono procedure (1 patient); David procedure (7 patients). Two patients underwent surgical treatment through mini-J-sternotomy. One patient also underwent CABG. Among the patients, there were two with previous surgeries (CABG and MIDCAB). Two techniques were used: the first variant – full surgical intervention was performed on a beating heart using continuous antegrade coronary myocardial perfusion in 8 patients; the second variant – a combination of cardioplegic cardiac arrest with coronary myocardial perfusion on a beating heart – 4 patients.During the study period, no patient died. Postoperative parameters (cardiac markers, electrocardiography (ECG), echocardiography) remained within normal limits. A number of complications were noted: one case of atrial fibrillation, terminated within the first day, one case of ventricular flutter intraoperatively with rhythm restoration after defibrillation, one case of mediastinal revision for hemostasis Results. During the study period, no patient died. Postoperative parameters (cardiac markers, ECG, echocardiography(EchoCG)) remained normal. The following complications were noted: 1 case of atrial fibrillation, terminated within the first day, 1 case of ventricular fibrillation intraoperatively with rhythm restoration after defibrillation, 1 case of mediastinal revision for hemostasis.Conclusion. Considering satisfactory intra- and postoperative data of surgical treatment of patients with aortic pathology on a beating heart with parallel cardiopulmonary bypass, as well as the absence of an increase in cardiac markers of myocardial damage in the perioperative period, we consider this technique applicable in surgical practice. Further development and use of the technique in aortic surgery on a beating heart using continuous antegrade coronary myocardial perfusion will reduce the myocardial stress during surgery, minimize the risks of postoperative complications and accelerate the patient's rehabilitation
- 13 July 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (2) , 159-167
Open AccessAortic root surgery in the beating heart: a case series
Aim: To describe the technique of surgical intervention on the aorta and aortic valve under working heart conditions with constant antegrade coronary myocardial perfusion and / or in combination with cardioplegic cardiac arrest; and also to assess the effectiveness of this method of myocardial protection and the possibility of its further use in aortic surgery.Materials and methods: From March to November 2024, 12 patients underwent planned surgery at the S.G. Sukhanov Federal Center for Cardiovascular Surgery of the Ministry of Health of Russia (Perm). The average age was 57.75±9.8 years – 10 men (83.7%), 2 women (16.3%). All of them underwent off-pump aortic replacement: supracoronary aortic replacement (1 patient); supracoronary aortic replacement and aortic valve replacement (1 patient); supracoronary aortic replacement and coronary artery bypass grafting (CABG) using radiofrequency ablation (RFA) (1 patient); Bentall-De Bono procedure (1 patient); David procedure (7 patients). Two patients underwent surgical treatment through mini-J-sternotomy. One patient also underwent CABG. Among the patients, there were two with previous surgeries (CABG and MIDCAB). Two techniques were used: the first variant – full surgical intervention was performed on a beating heart using continuous antegrade coronary myocardial perfusion in 8 patients; the second variant – a combination of cardioplegic cardiac arrest with coronary myocardial perfusion on a beating heart – 4 patients.During the study period, no patient died. Postoperative parameters (cardiac markers, electrocardiography (ECG), echocardiography) remained within normal limits. A number of complications were noted: one case of atrial fibrillation, terminated within the first day, one case of ventricular flutter intraoperatively with rhythm restoration after defibrillation, one case of mediastinal revision for hemostasis Results. During the study period, no patient died. Postoperative parameters (cardiac markers, ECG, echocardiography(EchoCG)) remained normal. The following complications were noted: 1 case of atrial fibrillation, terminated within the first day, 1 case of ventricular fibrillation intraoperatively with rhythm restoration after defibrillation, 1 case of mediastinal revision for hemostasis.Conclusion. Considering satisfactory intra- and postoperative data of surgical treatment of patients with aortic pathology on a beating heart with parallel cardiopulmonary bypass, as well as the absence of an increase in cardiac markers of myocardial damage in the perioperative period, we consider this technique applicable in surgical practice. Further development and use of the technique in aortic surgery on a beating heart using continuous antegrade coronary myocardial perfusion will reduce the myocardial stress during surgery, minimize the risks of postoperative complications and accelerate the patient's rehabilitation
- Open Access
- 1 January 2025
- Published by A.V. Vishnevsky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation in Minimally Invasive Cardiovascular Surgery
- Vol. 1 (1) , 84-90
REPLACEMENT OF THE ASCENDING AORTA AND AORTIC VALVE ON BEATING HEART
Цель исследования: рассмотреть возможности и преимущества хирургии аорты и аортального клапана на работающем сердце по сравнению с традиционной методикой, использующей искусственное кровообращение и кардиоплегию. Материалы и методы: представлен опыт протезирования восходящей аорты и аортального клапана на работающем сердце, что позволяет избежать остановки кровообращения и использования кардиоплегии. Результаты: положительный опыт показывает, что хирургия на работающем сердце способствует физиологическому сокращению миокарда и непрерывной перфузии, что снижает повреждение миокарда по сравнению с традиционными методами. Выводы: традиционная операция с кардиоплегической остановкой сопровождается «мандаторной ишемией», которая нарушает электролитный и кислородный баланс в миокарде и может приводить к метаболическим и структурным повреждениям. В связи с этим развивается практика проведения операций на работающем сердце с использованием постоянной коронарной ретроградной перфузии (ПКРП), что позволяет снизить длительность ишемии, уменьшить риск осложнений и повысить безопасность вмешательства. Представлены клинические случаи успешных операций по данной методике, а также результаты сравнительных исследований, демонстрирующих преимущества ПКРП по сравнению с традиционной кардиоплегией: сокращение времени операции, снижение послеоперационной летальности и осложнений, а также возможность более точной оценки патологии в физиологических условиях. В частности, отмечается эффективность метода при коррекции разрывов синуса Вальсальвы и при операциях на корне аорты и клапанах. В целом, использование хирургии на работающем сердце представляет перспективное направление для повышения безопасности и эффективности кардиохирургических вмешательств
- 1 January 2025
- Published by A.V. Vishnevsky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation in Minimally Invasive Cardiovascular Surgery
- Vol. 1 (1) , 84-90
Open AccessREPLACEMENT OF THE ASCENDING AORTA AND AORTIC VALVE ON BEATING HEART
Цель исследования: рассмотреть возможности и преимущества хирургии аорты и аортального клапана на работающем сердце по сравнению с традиционной методикой, использующей искусственное кровообращение и кардиоплегию. Материалы и методы: представлен опыт протезирования восходящей аорты и аортального клапана на работающем сердце, что позволяет избежать остановки кровообращения и использования кардиоплегии. Результаты: положительный опыт показывает, что хирургия на работающем сердце способствует физиологическому сокращению миокарда и непрерывной перфузии, что снижает повреждение миокарда по сравнению с традиционными методами. Выводы: традиционная операция с кардиоплегической остановкой сопровождается «мандаторной ишемией», которая нарушает электролитный и кислородный баланс в миокарде и может приводить к метаболическим и структурным повреждениям. В связи с этим развивается практика проведения операций на работающем сердце с использованием постоянной коронарной ретроградной перфузии (ПКРП), что позволяет снизить длительность ишемии, уменьшить риск осложнений и повысить безопасность вмешательства. Представлены клинические случаи успешных операций по данной методике, а также результаты сравнительных исследований, демонстрирующих преимущества ПКРП по сравнению с традиционной кардиоплегией: сокращение времени операции, снижение послеоперационной летальности и осложнений, а также возможность более точной оценки патологии в физиологических условиях. В частности, отмечается эффективность метода при коррекции разрывов синуса Вальсальвы и при операциях на корне аорты и клапанах. В целом, использование хирургии на работающем сердце представляет перспективное направление для повышения безопасности и эффективности кардиохирургических вмешательств
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (1) , 149-156
Hybrid surgery using a stent graft for DeBakey type III acute aortic dissection (case report)
Гибридная операция с использованием стент-графта при остром расслоении аорты III типа по DeBakey (клиническое наблюдение)
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (1) , 149-156
Hybrid surgery using a stent graft for DeBakey type III acute aortic dissection (case report)
Гибридная операция с использованием стент-графта при остром расслоении аорты III типа по DeBakey (клиническое наблюдение)
- Open Access
- 5 December 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (4) , 56-65
Comparison of the results of aortic valve neocuspidalization (Ozaki procedure) with aortic valve bioprosthetics in patients with a narrow aortic annulus: a multicenter retrospective study
In aortic valve (AV) replacement surgery in patients with a narrow annulus fibrosus (AF), the likelihood of prosthesis-patient mismatch (PPM) is high. PPM, in turn, significantly affects the hemodynamic and functional capabilities of AV, morbidity and mortality in the postoperative period. The “gold standard” for the treatment of AV diseases is prosthetics with mechanical and biological prostheses. However, there are alternative methods, such as neocuspidalization of AV according to the S. Ozaki (AVNeo) method.Aim: To compare the immediate and medium-term results of AV prosthetics using the S. Ozaki (AVNeo) technique and AV prosthetics with a biological prosthesis in patients with a small aortic annulus.Material and Methods: A retrospective multicenter study of 309 patients with a narrow fibrous ring of the aortic valve (FR AV) who underwent surgery between February 2010 and December 2021 was conducted. Inclusion criteria: prosthetics of AV, FR AV = 21 mm, age 18 years and older. Exclusion criteria: left ventricle ejection fraction ≤ 40%, repeated interventions, mini-stop. 153 patients underwent Aveo and 156 patients underwent AV prosthetics using biological prostheses. After “pseudorandomization” (propensity score matching), 92 patients were selected: 46 patients in the AVNeo group and 46 patients in the biological prosthesis group. The primary endpoint was hospital mortality. Postoperative complications, transvalvular gradients, and medium-term outcomes (three-year overall survival and freedom from surgery on AV) were evaluated as secondary endpoints.Results. There was no statistically significant difference in the duration of surgery (275.9 ± 34.2 min in the AVNeo group and 285.8 ± 37 min in the bioprosthesis group, p < 0.4), artificial circulation (98 min in the AVNeo group and 115 min in the bioprosthesis group, p < 0.3), aortic compression (80 min in the AVNeo group and 93 min in the bioprosthesis group, p < 0.7). Hospital mortality among the studied patients did not differ: in the AVNeo group – 2 (4.3%) and 1 (2.2%) in the bioprosthesis group, p = 1.0. There were no significant differences in postoperative complications: wound surface infection (3 (6.5%) in the AVNeo group and 1 (2.2%) in the bioprosthesis group, p = 0.617), acute kidney injury (1 (2.2%) in the AVNeo group and 0 in the bioprosthesis group, p = 1.0), stroke ( 1 (2.2%) in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 1.0), resternotomy for bleeding (0 in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 0.495). Permanent pacemaker implantation was not required by any patient. There was also no statistically significant difference in the three-year overall survival and re–operation, in the AVNeo group it was 83% and 92.5% in the bioprosthesis group, p = 0.23; three-year freedom from re-operation was 96.4% in the AVNeo group and 97.1% in the bioprosthesis group, p = 0.27. However, peak and average gradients were statistically less after AVNeo surgery. The peak and average gradients after AVNeo were 12 and 6 mmHg, after prosthetics 32 and 20 mmHg, p < 0.001.Conclusions: There was no statistically significant difference in hospital mortality, postoperative complications, and three-year survival and re-operation. The values of the peak and average pressure gradient at discharge differed statistically significantly in favor of the AVNeo group.
- 5 December 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (4) , 56-65
Open AccessComparison of the results of aortic valve neocuspidalization (Ozaki procedure) with aortic valve bioprosthetics in patients with a narrow aortic annulus: a multicenter retrospective study
In aortic valve (AV) replacement surgery in patients with a narrow annulus fibrosus (AF), the likelihood of prosthesis-patient mismatch (PPM) is high. PPM, in turn, significantly affects the hemodynamic and functional capabilities of AV, morbidity and mortality in the postoperative period. The “gold standard” for the treatment of AV diseases is prosthetics with mechanical and biological prostheses. However, there are alternative methods, such as neocuspidalization of AV according to the S. Ozaki (AVNeo) method.Aim: To compare the immediate and medium-term results of AV prosthetics using the S. Ozaki (AVNeo) technique and AV prosthetics with a biological prosthesis in patients with a small aortic annulus.Material and Methods: A retrospective multicenter study of 309 patients with a narrow fibrous ring of the aortic valve (FR AV) who underwent surgery between February 2010 and December 2021 was conducted. Inclusion criteria: prosthetics of AV, FR AV = 21 mm, age 18 years and older. Exclusion criteria: left ventricle ejection fraction ≤ 40%, repeated interventions, mini-stop. 153 patients underwent Aveo and 156 patients underwent AV prosthetics using biological prostheses. After “pseudorandomization” (propensity score matching), 92 patients were selected: 46 patients in the AVNeo group and 46 patients in the biological prosthesis group. The primary endpoint was hospital mortality. Postoperative complications, transvalvular gradients, and medium-term outcomes (three-year overall survival and freedom from surgery on AV) were evaluated as secondary endpoints.Results. There was no statistically significant difference in the duration of surgery (275.9 ± 34.2 min in the AVNeo group and 285.8 ± 37 min in the bioprosthesis group, p < 0.4), artificial circulation (98 min in the AVNeo group and 115 min in the bioprosthesis group, p < 0.3), aortic compression (80 min in the AVNeo group and 93 min in the bioprosthesis group, p < 0.7). Hospital mortality among the studied patients did not differ: in the AVNeo group – 2 (4.3%) and 1 (2.2%) in the bioprosthesis group, p = 1.0. There were no significant differences in postoperative complications: wound surface infection (3 (6.5%) in the AVNeo group and 1 (2.2%) in the bioprosthesis group, p = 0.617), acute kidney injury (1 (2.2%) in the AVNeo group and 0 in the bioprosthesis group, p = 1.0), stroke ( 1 (2.2%) in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 1.0), resternotomy for bleeding (0 in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 0.495). Permanent pacemaker implantation was not required by any patient. There was also no statistically significant difference in the three-year overall survival and re–operation, in the AVNeo group it was 83% and 92.5% in the bioprosthesis group, p = 0.23; three-year freedom from re-operation was 96.4% in the AVNeo group and 97.1% in the bioprosthesis group, p = 0.27. However, peak and average gradients were statistically less after AVNeo surgery. The peak and average gradients after AVNeo were 12 and 6 mmHg, after prosthetics 32 and 20 mmHg, p < 0.001.Conclusions: There was no statistically significant difference in hospital mortality, postoperative complications, and three-year survival and re-operation. The values of the peak and average pressure gradient at discharge differed statistically significantly in favor of the AVNeo group.
- Open Access
- 22 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 40 (6) , 61-73
Immediate and medium-term results of aortic valve replacement with biological prosthesis in elderly patients: experience of one center
Objective. To analyze the immediate and medium-term results of prosthetics of the aortic valve (AV) using biological prosthesis in elderly patients. Material and methods. The study included 198 patients with AV pathology [85 men (42.9 %)/113 women (57.1 %)]. The median age was 70 [66–73] years. There were 175 (88.4 %) patients with sclerodegenerative AV, 5 (2.5 %) – with infectious endocarditis and 30 patients (15.2 %) had bicuspid AV. Results. The hospital mortality was 4.5 %. The causes of mortality were multiple organ failure syndrome, in 1 case – developed peritonitis. In 14 patients (7.1 %) there was a rhythm disturbance in the form of AF, in 9 (4.5 %) – a complete AV block, in connection with which a permanent pacemaker was implanted. Four patients (2 %) underwent resternotomy for bleeding. Two patients (1 %) underwent pericardiocentesis. 8 (4 %) patients developed a stroke. No wound complications were detected. In the long-term period, 31 patients died. The causes of mortality were the following: cardiovascular diseases – 13 patients, malignant neoplasms – 5 patients, gastrointestinal diseases – 2, urinary system disease – 1 patient, COVID-19 – 1 patient, unknown cause – 9 patients. Thus, the five-year survival rate after the surgery was 63 %, respectively. During the follow-up period, 2 patients (2.9 %) underwent repeated intervention on AV. Conclusions. The five-year freedom from re-operation was 97.1 %. The five-year survival rate was 63 % due to the presence of a history of severe concomitant pathology as well as the middle age of patients 70 years.
- 22 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 40 (6) , 61-73
Open AccessImmediate and medium-term results of aortic valve replacement with biological prosthesis in elderly patients: experience of one center
Objective. To analyze the immediate and medium-term results of prosthetics of the aortic valve (AV) using biological prosthesis in elderly patients. Material and methods. The study included 198 patients with AV pathology [85 men (42.9 %)/113 women (57.1 %)]. The median age was 70 [66–73] years. There were 175 (88.4 %) patients with sclerodegenerative AV, 5 (2.5 %) – with infectious endocarditis and 30 patients (15.2 %) had bicuspid AV. Results. The hospital mortality was 4.5 %. The causes of mortality were multiple organ failure syndrome, in 1 case – developed peritonitis. In 14 patients (7.1 %) there was a rhythm disturbance in the form of AF, in 9 (4.5 %) – a complete AV block, in connection with which a permanent pacemaker was implanted. Four patients (2 %) underwent resternotomy for bleeding. Two patients (1 %) underwent pericardiocentesis. 8 (4 %) patients developed a stroke. No wound complications were detected. In the long-term period, 31 patients died. The causes of mortality were the following: cardiovascular diseases – 13 patients, malignant neoplasms – 5 patients, gastrointestinal diseases – 2, urinary system disease – 1 patient, COVID-19 – 1 patient, unknown cause – 9 patients. Thus, the five-year survival rate after the surgery was 63 %, respectively. During the follow-up period, 2 patients (2.9 %) underwent repeated intervention on AV. Conclusions. The five-year freedom from re-operation was 97.1 %. The five-year survival rate was 63 % due to the presence of a history of severe concomitant pathology as well as the middle age of patients 70 years.
- 6 November 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (12) , 5666-5669
Minimizing visceral organ ischemia time for open repair of thoracoabdominal aortic disease: Description of a new method
Minimizing ischemic injury during surgical repair of thoracoabdominal aortic aneurysms (TAAAs) is vital for preventing complications such as paraplegia and acute renal failure. In this report, we describe a new technique for TAAA open repair that aims to minimize visceral organ ischemia times. Unlike typical Crawford extent II TAAA open repair, which begins with aortic clamping and proceeds from the proximal to the distal anastomoses, our method reverses the anastomosis order and minimizes aortic clamping. Between January 2016 and December 2020, we used this approach in 29 patients undergoing TAAA repair. We present one of these cases, a 29-year-old patient with progressive aneurysmal dilatation of a DeBakey type III chronic aortic dissection that extended beyond the aortic bifurcation. Our technique reduced aortic cross-clamping, left heart bypass, and internal organ and spinal cord ischemia times and appears to be safe and effective.
- 6 November 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (12) , 5666-5669
Minimizing visceral organ ischemia time for open repair of thoracoabdominal aortic disease: Description of a new method
Minimizing ischemic injury during surgical repair of thoracoabdominal aortic aneurysms (TAAAs) is vital for preventing complications such as paraplegia and acute renal failure. In this report, we describe a new technique for TAAA open repair that aims to minimize visceral organ ischemia times. Unlike typical Crawford extent II TAAA open repair, which begins with aortic clamping and proceeds from the proximal to the distal anastomoses, our method reverses the anastomosis order and minimizes aortic clamping. Between January 2016 and December 2020, we used this approach in 29 patients undergoing TAAA repair. We present one of these cases, a 29-year-old patient with progressive aneurysmal dilatation of a DeBakey type III chronic aortic dissection that extended beyond the aortic bifurcation. Our technique reduced aortic cross-clamping, left heart bypass, and internal organ and spinal cord ischemia times and appears to be safe and effective.
- 4 June 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (9) , 2873-2878
Surgical treatment of Kommerell's diverticulum
Kommerell's diverticulum (KD) is a rare congenital vascular abnormality due to the formation of an abnormal aortic arch, most commonly associated with dilatation at the proximal part of the aberrant subclavian artery. This article describes an option of surgical treatment in a patient with KD. The proposed new technique of aortic arch surgical reconstruction with a stent‐graft placement in the descending aorta reduces CPB time, aortic clamp and circulatory arrest time.
- 4 June 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (9) , 2873-2878
Surgical treatment of Kommerell's diverticulum
Kommerell's diverticulum (KD) is a rare congenital vascular abnormality due to the formation of an abnormal aortic arch, most commonly associated with dilatation at the proximal part of the aberrant subclavian artery. This article describes an option of surgical treatment in a patient with KD. The proposed new technique of aortic arch surgical reconstruction with a stent‐graft placement in the descending aorta reduces CPB time, aortic clamp and circulatory arrest time.
- Open Access
- 9 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 155-161
Repeated prosthetics of the ascending aorta and aortic arch with a homograft for prosthesis infection and ruptured aorta after Bentalla de Bono operation
Prosthetic vascular graft infection is a formidable complication after cardiac surgery. Until now, the question on the tactics of managing such patients remains open, as well as the timing of each of the treatment methods such as conservative antibiotic therapy and surgery. In addition, the choice of a method of surgical treatment in itself poses new questions for specialists in regard to what methods to adhere to including prosthesis-preserving technique, prosthesis explantation and its replacement with a synthetic or biological graft, and the use of omentum to cover the infected bed. We present a case of treating a patient with an infected synthetic valve-containing conduit after Bentall de Bono operation and aortic rupture with the formation of false aneurysms. Attention is drawn to the prolonged clinical patient condition manifesting with fever, and the lack of data suggesting an infectious process according to positron-emission tomography and blood cultures. We chose a homograft of the ascending aortic and aortic arch with aortic valve as a conduit. It is also of interest that cultures of infectious prosthesis and aortic valve did not reveal any infectious agent. Aggressive antibiotic therapy in combination with surgical replacement of the infected prosthesis with a cryoprepared allograft allowed for successful treatment of patient without complications.
- 9 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 155-161
Open AccessRepeated prosthetics of the ascending aorta and aortic arch with a homograft for prosthesis infection and ruptured aorta after Bentalla de Bono operation
Prosthetic vascular graft infection is a formidable complication after cardiac surgery. Until now, the question on the tactics of managing such patients remains open, as well as the timing of each of the treatment methods such as conservative antibiotic therapy and surgery. In addition, the choice of a method of surgical treatment in itself poses new questions for specialists in regard to what methods to adhere to including prosthesis-preserving technique, prosthesis explantation and its replacement with a synthetic or biological graft, and the use of omentum to cover the infected bed. We present a case of treating a patient with an infected synthetic valve-containing conduit after Bentall de Bono operation and aortic rupture with the formation of false aneurysms. Attention is drawn to the prolonged clinical patient condition manifesting with fever, and the lack of data suggesting an infectious process according to positron-emission tomography and blood cultures. We chose a homograft of the ascending aortic and aortic arch with aortic valve as a conduit. It is also of interest that cultures of infectious prosthesis and aortic valve did not reveal any infectious agent. Aggressive antibiotic therapy in combination with surgical replacement of the infected prosthesis with a cryoprepared allograft allowed for successful treatment of patient without complications.
- Open Access
- 4 January 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 36 (4) , 107-119
Early and late outcomes of combined and staged surgeries in patients with concomitant atherosclerotic lesions of the coronary and brachiocephalic arteries
Objective. To study the early and late outcomes of surgical treatment of patients with concomitant atherosclerotic lesions of coronary and brachiocephalic arteries while choosing a treatment strategy based on the developed diff erentiated approach algorithm.Material and Methods. The study comprised 243 patients with combined atherosclerotic lesions of the coronary and carotid arteries examined during the period from 01.07.2014 to 01.01.2021. Patients underwent revascularization surgeries based on the algorithm for choosing the volume and stages of surgical intervention, which was previously developed in the Federal Center for Cardiovascular Surgery named after S.G. Sukhanov. A single-stage combined surgery of coronary artery bypass grafting (CABG) and carotid endarterectomy (CEE) was performed in 104 patients (42.8%); 139 patients (57.2%) received staged revascularization including 102 patients (73.4%) who received CABG as the fi rst step and 37 patients (26.6%) who received CEE as the fi rst step of surgery. The endpoints for both early and late results were death from all causes, stroke, transient ischemic attack (TIA), acute myocardial infarction (AMI), and combined endpoint that included all of the above. Average follow-up time was 41.1 ± 21.8 months.Results. No fatal outcomes were in any group during the early postoperative period. At the hospital stage, there were 5 cases (2.1%) of stroke, 1 case (0.4%) of TIA, and 3 cases (1.2%) of acute MI. Long-term results were evaluated in 225 patients (92.3%). The overall survival rate was 93.8%. There were 5 cases (2.4%) of MI, 11 cases (4.9%) of stroke, and 1 case (1.0%) of TIA. No signifi cant diff erences were observed in immediate and long-term endpoints between the groups of staged and combined interventions as compared to immediate (AMI: p = 0.680; TIA: p = 0.500; acute cerebrovascular events: p = 0.567; combined: p = 0.940) and long-term results (deaths: 0.860; AMI: p = 0.906; TIA: p = 0.528; acute cerebrovascular events: p = 0.378; combined: p = 0.669).Conclusion. Based on successful experience with treating the concomitant atherosclerotic lesions of the coronary and brachiocephalic arteries, the proposed algorithm allowed to perform safe procedures in both arterial basins and to achieve satisfactory results in in-hospital and long-term periods in the Federal Center for Cardiovascular Surgery named after S.G. Sukhanov (Perm).
- 4 January 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 36 (4) , 107-119
Open AccessEarly and late outcomes of combined and staged surgeries in patients with concomitant atherosclerotic lesions of the coronary and brachiocephalic arteries
Objective. To study the early and late outcomes of surgical treatment of patients with concomitant atherosclerotic lesions of coronary and brachiocephalic arteries while choosing a treatment strategy based on the developed diff erentiated approach algorithm.Material and Methods. The study comprised 243 patients with combined atherosclerotic lesions of the coronary and carotid arteries examined during the period from 01.07.2014 to 01.01.2021. Patients underwent revascularization surgeries based on the algorithm for choosing the volume and stages of surgical intervention, which was previously developed in the Federal Center for Cardiovascular Surgery named after S.G. Sukhanov. A single-stage combined surgery of coronary artery bypass grafting (CABG) and carotid endarterectomy (CEE) was performed in 104 patients (42.8%); 139 patients (57.2%) received staged revascularization including 102 patients (73.4%) who received CABG as the fi rst step and 37 patients (26.6%) who received CEE as the fi rst step of surgery. The endpoints for both early and late results were death from all causes, stroke, transient ischemic attack (TIA), acute myocardial infarction (AMI), and combined endpoint that included all of the above. Average follow-up time was 41.1 ± 21.8 months.Results. No fatal outcomes were in any group during the early postoperative period. At the hospital stage, there were 5 cases (2.1%) of stroke, 1 case (0.4%) of TIA, and 3 cases (1.2%) of acute MI. Long-term results were evaluated in 225 patients (92.3%). The overall survival rate was 93.8%. There were 5 cases (2.4%) of MI, 11 cases (4.9%) of stroke, and 1 case (1.0%) of TIA. No signifi cant diff erences were observed in immediate and long-term endpoints between the groups of staged and combined interventions as compared to immediate (AMI: p = 0.680; TIA: p = 0.500; acute cerebrovascular events: p = 0.567; combined: p = 0.940) and long-term results (deaths: 0.860; AMI: p = 0.906; TIA: p = 0.528; acute cerebrovascular events: p = 0.378; combined: p = 0.669).Conclusion. Based on successful experience with treating the concomitant atherosclerotic lesions of the coronary and brachiocephalic arteries, the proposed algorithm allowed to perform safe procedures in both arterial basins and to achieve satisfactory results in in-hospital and long-term periods in the Federal Center for Cardiovascular Surgery named after S.G. Sukhanov (Perm).